FTC Advertising Compliance Review

The FTC polices unfair or deceptive acts in commerce — including false claims, inadequate substantiation, and hidden material connections in endorsements. An FTC-focused review examines your marketing through that lens before complaints, investigations, or competitor challenges arise.

Schedule a Consultation

Schedule an FTC compliance review with Natascia Taken, Esq..

Schedule Consultation

FTC authority over brand advertising

The Federal Trade Commission enforces Section 5 of the FTC Act against deceptive and unfair advertising practices across industries. Unlike the FDA, the FTC does not approve products — but it can require substantiation, mandate corrective advertising, impose civil penalties in certain cases, and pursue relief through administrative and federal court proceedings. Health, wellness, and financial claims receive particular scrutiny.

The FTC evaluates advertisements holistically: headlines, visuals, testimonials, fine print, and ordering of information all contribute to the net impression conveyed to reasonable consumers. Omitting material limitations or qualifying information can be as problematic as an outright false statement.

State attorneys general frequently enforce state consumer protection laws in parallel with the FTC, particularly for subscription traps, fake reviews, and health fraud. NAD competitor challenges can force claim changes even when no government investigation is pending. An FTC compliance review considers how your materials may fare across these forums.

Core pillars of an FTC compliance review

Truthfulness and substantiation

Objective claims require a reasonable basis before publication. For health-related products, the FTC typically expects competent and reliable scientific evidence. The agency's Health Products Compliance Guidance outlines factors it considers when evaluating diet, supplement, and similar advertising.

Endorsements and testimonials

The FTC Endorsement Guides address influencers, expert endorsers, consumer reviews, and affiliate marketers. Endorsers must reflect honest opinions, and material connections must be disclosed clearly. Brands cannot use testimonials that they know or should know are deceptive, including atypical results presented without clear disclosure.

For a practical overview, see the FTC's consolidated guidance on endorsements and influencer marketing.

Disclosures and fine print

  • Required disclosures must be clear, conspicuous, and proximate to the claim they modify
  • Hyperlinks to terms are insufficient when consumers are unlikely to click
  • Free trial and negative option offers trigger additional ROSCA and Telemarketing Sales Rule considerations
  • Environmental and "green" claims face heightened substantiation under updated FTC guidance

What Natascia Taken, Esq. reviews

Engagements typically include analysis of website and ad copy, email and SMS flows, subscription checkout paths, review and UGC programs, influencer contracts and published posts, and comparative advertising. Findings are prioritized by enforcement likelihood and business impact so your team can address high-exposure items first.

For DTC brands, checkout flows and post-purchase email sequences often contain claims absent from the homepage — abandoned cart messages, upsell screens, and loyalty program copy are frequently overlooked. Subscription and auto-ship offers implicate additional ROSCA and Telemarketing Sales Rule analysis when "free trial" language is involved.

Triggers that increase FTC exposure

National advertising campaigns, aggressive weight-loss or income claims, fake review patterns, and viral influencer promotions draw attention. Consumer complaints to the FTC, NAD challenges, and state AG referrals can follow. Periodic FTC-focused review is especially valuable when marketing teams scale faster than compliance processes.

Documenting compliance efforts

If the FTC inquires, your ability to show pre-dissemination review, substantiation files, and corrective action history may influence how matters are resolved. Natascia Taken, Esq. can help identify documentation gaps during review so your compliance story is supported by records, not just intent.

Integrating FTC review with broader compliance

FTC findings often overlap with FDA claim categories, platform ad policies, and retailer vendor standards. A coordinated review prevents fixing an FTC disclosure issue while leaving an impermissible disease claim live on the same landing page. Natascia Taken, Esq. flags these intersections so remediation is comprehensive rather than siloed by channel.

Post-review, many clients implement claim approval checklists and substantiation cross-reference templates so future campaigns inherit the same standards without repeating full engagements for every asset.

This service provides legal education and risk assessment — not assurance that the FTC will agree with every business judgment or that enforcement will never occur.

Related Guides

Frequently Asked Questions

Does the FTC regulate our industry if FDA also does?+

Yes. FDA and FTC jurisdiction overlaps for many health and consumer products. The FDA focuses on product labeling and certain claim categories; the FTC enforces advertising truthfulness and substantiation broadly. Compliance with one agency's rules does not automatically satisfy the other.

What is the National Advertising Division (NAD)?+

NAD is a self-regulatory forum where competitors challenge advertising claims. NAD decisions do not carry fines but often require claim modification and may refer unresolved matters to the FTC. Many brands treat NAD complaints as seriously as regulatory inquiries.

Can the FTC fine us for first-time violations?+

Penalty authority depends on conduct, prior orders, and applicable rules. Some violations carry civil penalty exposure; others may result in corrective action without immediate fines. Facts and enforcement context determine outcomes.

How is an FTC review different from a general advertising review?+

General advertising reviews often balance FDA claim categories with FTC standards. An FTC-focused review emphasizes Section 5 deception analysis, substantiation files, endorsement practices, and offer terms — with less emphasis on FDA labeling technicalities unless they appear in advertising.

Schedule a Consultation

Schedule Consultation

This content is for general informational purposes only and is not legal advice. Prior results do not guarantee future outcomes. Attorney Advertising.